T cell responses to SARS-CoV-2

A Sette, J Sidney, S Crotty - Annual review of immunology, 2023 - annualreviews.org
A large body of evidence generated in the last two and a half years addresses the roles of T
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …

Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines

A Sette, S Crotty - Immunological reviews, 2022 - Wiley Online Library
Immunological memory is the basis of protective immunity provided by vaccines and
previous infections. Immunological memory can develop from multiple branches of the …

N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting

TE Mulroney, T Pöyry, JC Yam-Puc, M Rust, RF Harvey… - Nature, 2024 - nature.com
In vitro-transcribed (IVT) mRNAs are modalities that can combat human disease, exemplified
by their use as vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection

V Hall, S Foulkes, F Insalata, P Kirwan… - … England Journal of …, 2022 - Mass Medical Soc
Background The duration and effectiveness of immunity from infection with and vaccination
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relevant to …

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

M Lipsitch, F Krammer, G Regev-Yochay… - Nature Reviews …, 2022 - nature.com
Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in fully vaccinated individuals are receiving intense scrutiny because of their importance …

Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines

JE Bowen, A Addetia, HV Dang, C Stewart, JT Brown… - Science, 2022 - science.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of
concern comprises several sublineages, with BA. 2 and BA. 2.12. 1 having replaced the …

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK …

ASV Stuart, RH Shaw, X Liu, M Greenland, PK Aley… - The Lancet, 2022 - thelancet.com
Background Given the importance of flexible use of different COVID-19 vaccines within the
same schedule to facilitate rapid deployment, we studied mixed priming schedules …

Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination

B Pozzetto, V Legros, S Djebali, V Barateau, N Guibert… - Nature, 2021 - nature.com
Following severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine,,
European health authorities recommended that patients under the age of 55 years who …

Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age

SHX Tan, AR Cook, D Heng, B Ong… - New England Journal …, 2022 - Mass Medical Soc
Background Since it was first identified in early November 2021, the B. 1.1. 529 (omicron)
variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread …

Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity

LB Rodda, PA Morawski, KB Pruner, ML Fahning… - Cell, 2022 - cell.com
Immune memory is tailored by cues that lymphocytes perceive during priming. The severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic created a situation in …